RT Journal Article
SR Electronic
T1 Cohort Profile: Baseline Characteristics of Veterans from Improving Veteran Access to Integrated Management of Back Pain (AIM-Back) – an Embedded Pragmatic, Cluster Randomized Trial in the United States
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.11.23.24317833
DO 10.1101/2024.11.23.24317833
A1 George, Steven Z.
A1 France, Courtni
A1 Coffman, Cynthia J.
A1 Allen, Kelli D.
A1 Lentz, Trevor A.
A1 North, Rebecca
A1 Choate, Ashley
A1 Goode, Adam P.
A1 Simon, Corey B.
A1 Grubber, Janet M.
A1 King, Heather
A1 Cook, Chad E.
A1 Keefe, Francis J.
A1 Ballengee, Lindsay A.
A1 Naylor, Jennifer
A1 Brothers, Joseph Leo
A1 Stanwyck, Catherine
A1 Linton, Travis
A1 Tumminello, Christa
A1 Hastings, S. Nicole
YR 2024
UL http://medrxiv.org/content/early/2024/11/26/2024.11.23.24317833.abstract
AB Purpose AIM-Back is an embedded pragmatic clinical trial (ePCT) with cluster randomization designed to increase access and compare the effectiveness of two different non-pharmacological care pathways for low back pain (LBP) delivered within the Veteran Administration Health Care System (VAHCS). This manuscript describes baseline characteristics of AIM-Back participants as well as the representativeness of those referred to the AIM-Back program by sex, age, race, and ethnicity, relative to Veterans with low back pain at participating clinics.Participants To be eligible for AIM-Back, Veterans were referred to the randomized pathway at their clinic by trained primary care providers (Referral cohort). Veterans from the Referral cohort that participated in the study included: 1) an Electronic Health Record (EHR) sample of Veterans enrolled in the program (i.e., attended initial AIM-Back visit with no consent required) and a Survey sample of Veterans that were consented for further study. Descriptive statistics for age, race, ethnicity, sex, high-impact chronic pain (HICP), a comorbidity measure, post-traumatic stress diagnosis (PTSD) and opioid exposure were reported for the Referral cohort and by sample; mean baseline PROMIS pain interference, physical function and sleep disturbance scores were reported by sample. Additional measures of pain, mental health and social risk were reported on the Survey sample. Participation to prevalence ratios (PPRs) were calculated for sex, age, race, and ethnicity by clinic to describe representativeness of the Referral cohort.Findings to Date Across 17 randomized primary care clinics, the Referral cohort included 2767 unique Veterans with n=1817 in the EHR sample, n=996 in the Survey sample and n=799 of the EHR sample (44%) were also in the Survey sample. High rates of HICP were observed in the EHR and Survey samples (>59%). Mean scores (SD) based on self-reported PROMIS Pain Interference (63.2 (6.8), 63.1 (6.6)) and PROMIS Physical Function (37.1 (5.3), 38.1 (5.8)) indicated moderate impairment in the EHR sample and Survey sample respectively. Approximately 10% of the EHR sample had documented opioid use in the year leading up to the AIM-Back referral. At most clinics, older Veterans (>=65 years) were underrepresented in the Referral cohort compared to those with LBP visits at clinics (PPRs < 0.8).Future Plans The AIM-Back trial will conduct analysis to examine the comparative effectiveness of the two care pathways and identify individual characteristics that may improve responses to each pathway. The trial is expected to complete 12-month follow-up data collection by December 2024, with subsequent analyses and publications providing insights into optimizing non-pharmacological care for Veterans with LBP.Trial Registration NCT04411420 (clinicaltrials.gov)StrengthsEmbedded features (e.g., EHR documentation and clinical staff serving as interventionist) of the AIM-Back trial have potential to facilitate implementation of these care pathways more broadly in Veteran’s Health Administration clinics and in health systems outside the Veteran’s Health AdministrationParticipating clinics were in 10 states providing regional geographic representation across the study.Trial was delivered within an integrated health system optimal for consistent documentation templates and data extraction across the trial sites.LimitationsDue to clinical personnel’s role in participant recruitment, sample biases may exist in those referred to the program and/or those who agreed to participate in additional surveysThese findings may not be generalizable to older aged Veterans due to our lower enrollment of those 65+.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04411420Funding StatementThis work is supported through cooperative agreement UH3AT009790 from the NIH, National Center for Complimentary and Integrative Health (NCCIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health the U.S Department of Veterans Affairs or the United States Government This manuscript is a product of the Pain Management Collaboratory. For more information about the Collaboratory, visit https://painmanagementcollaboratory.org/. This material is the result of work supported with resources and the use of facilities at the Durham VA Health Care System in Durham North Carolina.  Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Duke University and Durham VA gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors, after the primary outcomes are reported in a peer-reviewed manuscript